Essays about: "pricing pharmaceutical"

Showing result 1 - 5 of 16 essays containing the words pricing pharmaceutical.

  1. 1. Paying the Piper : The Consequences of Including Generic Prices in Reimbursement Decisions for Prescription Pharmaceuticals

    University essay from Linköpings universitet/Nationalekonomi; Linköpings universitet/Filosofiska fakulteten

    Author : Anton Klockhoff; Wilmer Larsson; [2023]
    Keywords : pharmaceutical reimbursement; genericization; endogenous pricing; treatment displacement; cost-effectiveness analysis; R D incentives;

    Abstract : Objectives: The Dental and Pharmaceutical Benefits Agency (TLV) is responsible for deciding which prescription pharmaceuticals should be subsidized in Sweden. Cost-effectiveness analyses are fundamental to its decision-making, but future price reductions following patent expiry are excluded from these analyses. READ MORE

  2. 2. The Effect of Competition on the Pricing of Dental Treatments for Private Clinics in Sweden

    University essay from Handelshögskolan i Stockholm/Institutionen för redovisning och finansiering

    Author : Kevin Mohseni; [2022]
    Keywords : price competition; dental industry; private clinics;

    Abstract : The purpose of this study was to evaluate if and how competition affected the pricing of dental treatments for private clinics in Sweden. The proximity to other clinics was used as a measure of competition. READ MORE

  3. 3. Financial Justifications for the Software-as-a-Service Business Model Trend Based on Financial Differences between Companies in the Software-as-a-Service and Pharmaceutical Industry

    University essay from Göteborgs universitet/Företagsekonomiska institutionen

    Author : Johannes Lindvall; Daniel Olsson; [2021-02-24]
    Keywords : Software-as-a-Service; Pharmaceutical; Financial differences;

    Abstract : The Software-as-a-Service (SaaS) business model is a new type of business model that has gained great attention from both researchers and practitioners. The rapid growth has resulted in a more and more refined business model and is described as the future of software. Thus, it is not unexpected that the model is frequently used for many start-ups. READ MORE

  4. 4. Exploring the reasons to shortage of antibiotics in pharmacies : A case study on Sweden

    University essay from

    Author : Gabriel Chivi; [2020]
    Keywords : Antibiotics; resistance; sustainability; supply chain management; pharmaceutical supply chains; pharmacies; Product of the Period;

    Abstract : The increased use of antibiotics is considered to be correlated to the increased resistance against antibiotics, hence responsible use is necessary for it to remain efficient and sustainable. To mitigate the resistance, a wide variety of antibiotics should be made available with different Active Pharmaceutical Ingredients (API), providing patients with more aimed cures rather than just few general antibiotics applied for several diseases. READ MORE

  5. 5. EU Competition Law under Ordoliberalism - A case study of Excessive Pricing in Pharmaceutical Sector

    University essay from Malmö universitet/Fakulteten för kultur och samhälle (KS)

    Author : Ngoc Nha Tinh Tran; [2020]
    Keywords : Ordoliberalism; European Union; EU competition policy; excessive pricing; pharmaceutical industry; public health; pricing regulation; abuse of dominant positions;

    Abstract : The purpose of this study is to conceptualize the ideational influence of Ordoliberalism on EU Competition Law while addressing a problematic social issue that has been witnessing a surge in the number of cases, which is excessive price abuse under Article 102(a) of the Treaty on the Functioning of the European Union (TFEU) within the spectrum of pharmaceutical sector. By utilizing Nedergaard (2020)’s analytic framework for Ordoliberalism’s operationalization, the study successfully proves the impacts of five characteristics of Ordoliberalism, including Politics by rules, Economic Constitution, Market Construction, Role of Consumers and Role of the states towards consumers, on the practices of EU Competition Law, using the empirical data collected from two excessive pricing examples: Aspen in Italy and Pfizer/Flynn in the United Kingdom. READ MORE